Y
Yalei Zhang
Researcher at Fudan University
Publications - 4
Citations - 100
Yalei Zhang is an academic researcher from Fudan University. The author has contributed to research in topics: Immunotherapy & Medicine. The author has an hindex of 2, co-authored 4 publications receiving 10 citations. Previous affiliations of Yalei Zhang include Fudan University Shanghai Medical College.
Papers
More filters
Journal ArticleDOI
Emerging strategies to target RAS signaling in human cancer therapy.
TL;DR: This work fully review RAS mutations in human cancer and especially focus on emerging strategies that have been recently developed for RAS-targeting therapy.
Journal ArticleDOI
Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy.
TL;DR: In this paper, the authors summarized the mechanisms and applications of oncolytic viruses against the immunosuppressive TME, and strategies of OVs in combination with immunotherapy.
Journal ArticleDOI
Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective.
TL;DR: In this article, the authors discuss the tumor-infiltrated B cells' subpopulations, differentiation trajectory, and interactions with other cells in the tumor microenvironment (TME).
Journal ArticleDOI
Circulating EVs long RNA-based subtyping and deconvolution enable prediction of immunogenic signatures and clinical outcome for PDAC
Yuchen Li,Yuchen Li,Ye Li,Ye Li,Shulin Yu,Shulin Yu,Ling Qian,Ling Qian,Kun Chen,Kun Chen,Hongyan Lai,Hongyan Lai,Hena Zhang,Hena Zhang,Yan Li,Yan Li,Yalei Zhang,Yalei Zhang,Sijia Gu,Sijia Gu,Zhiqiang Meng,Zhiqiang Meng,Shenglin Huang,Shenglin Huang,Peng Wang,Peng Wang +25 more
TL;DR: In this article, the authors developed a circulating extracellular vesicle (cEV) long RNA (exLR)-based PDAC subtyping method and provided exLR-derived signatures for predicting immunogenic features and clinical outcomes.